Conferences - Results from #8780

IBCN 2017: Biomarkers October 22, 2017

IBCN 2017: Building on past failures - new approaches to clinical trials for muscle-invasive bladder cancer October 22, 2017

IBCN 2017: Focus on biomarker driven clinical trial design in bladder cancer October 22, 2017

IBCN 2017: Improving neoadjuvant chemotherapy for muscle invasive bladder cancer October 22, 2017

IBCN 2017: Trial design for BCG unresponsive Non-Muscle Invasive Bladder Cancer October 22, 2017

IBCN 2017: Urologist-Led Success Stories in Stewardship of Imaging for Bladder Cancer October 22, 2017

AUA QI Summit 2017: Urologist-Led Success Stories in Stewardship of Imaging for Prostate Cancer October 22, 2017

AUA QI Summit 2017: Potentially Avoidable Harms from Radiation: Keynote Address October 22, 2017

AUA QI Summit 2017: Need for Physician-Led Stewardship of Imaging in Urology October 22, 2017

AUA QI Summit 2017: National Quality Initiatives in Renal Colic Imaging from the American College of Emergency Physicians (ACEP) October 22, 2017

AUA QI Summit 2017: Optimizing Implementation of Prostate MRI October 22, 2017

SIU 2017: ProtecT, PIVOT and SPCG-4: Placing New Evidence into Context October 22, 2017

SIU 2017: Evidence-Based Outcomes in Oncology: Implications for Patient Care October 22, 2017

SIU 2017: American Urological Association Lecture - Adrenal Imaging: A Urologist’s Perspective October 22, 2017

SIU 2017: Translational Observations from Mutation Profiling of Muscle Invasive Bladder Cancer October 22, 2017

SIU 2017: ProtecT in 2017: What Have We Learnt? October 22, 2017

SIU 2017: MRI As a Triage Test in Prostate Cancer Diagnostic Algorithm in Biopsy - Naïve Men: A Prospective Study October 22, 2017

SIU 2017: Economic Effectiveness of Urinary PCA3 Test in Cases of Serum PSA Level 4-10 Ng/Ml October 22, 2017

SIU 2017: Neoadjuvant Chemo - When, What and Why? October 22, 2017

SIU 2017: Can Genetic Analysis in Bladder Cancer Enhance Decision Making October 22, 2017

Page 440 of 594